Conavi Medical Corp. (QTNA)
Market Closed
12 Dec, 20:00
XFRA 
TSX-V Primary XFRA €
0. 28
-0.02
-6.71%
€
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
€ 0.3
Previous Close Day Range
0.28 0.28
Year Range
0.2 0.52
Want to track QTNA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
QTNA closed Friday lower at €0.28, a decrease of 6.71% from Thursday's close, completing a monthly decrease of -8.55% or €0.03. Over the past 12 months, QTNA stock lost -32.2%.
QTNA is not paying dividends to its shareholders.
The last earnings report, released on May 12, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Conavi Medical Corp. has completed 1 stock splits, with the recent split occurring on Oct 17, 2024.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on TSX-V (CAD).
QTNA Chart
Conavi Medical Corp. (QTNA) FAQ
What is the stock price today?
The current price is €0.28.
On which exchange is it traded?
Conavi Medical Corp. is listed on TSX-V.
What is its stock symbol?
The ticker symbol is QTNA.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0%.
What is its market cap?
As of today, no market cap data is available.
Has Conavi Medical Corp. ever had a stock split?
Conavi Medical Corp. had 1 splits and the recent split was on Oct 17, 2024.
Conavi Medical Corp. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Mr. Thomas Looby CEO | XFRA Exchange | CA88830X8199 ISIN |
| Canada Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Conavi Medical Corp. is a pioneering company based in Toronto, Canada, dedicated to the advancement of imaging technologies for minimally invasive cardiovascular procedures. With a strong focus on innovation, Conavi Medical Corp. designs, manufactures, and markets state-of-the-art solutions intended to enhance the precision and safety of such interventions. Their commitment to improving patient outcomes and supporting healthcare professionals is evident through their development of groundbreaking imaging systems that combine various imaging modalities for comprehensive coronary artery analysis.
Products and Services
- Novasight Hybrid System - This revolutionary system represents a significant advancement in imaging technology for cardiovascular care. By integrating intravascular ultrasound (IVUS) with optical coherence tomography (OCT), the Novasight Hybrid System provides simultaneous and co-registered imaging capabilities. This dual-modality approach allows for a more detailed and accurate visualization of coronary arteries, facilitating better decision-making during common minimally invasive procedures. The system underscores Conavi Medical Corp.'s dedication to enhancing the quality of care for patients undergoing cardiovascular interventions.
Contact Information
Address: 293 Lesmill Road
Phone: -
Website: https://conavi.com
2025 © Marketlog. All Rights Reserved.
